日本語 
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Shonan iPark and LabCentral Forge Strategic Partnership to Propel Asian Biotech Startups into U.S. Ecosystem
Shonan iPark, a leading life sciences hub in Japan, has teamed up…
Novo Nordisk Acquires Akero Therapeutics for Up to US$ 5.2 Billion: Implications for Japan’s Biotech and Tech Industries
In October 2025, Novo Nordisk, a Danish pharma company, announced it will…
UK and Japan Forge Strategic Biotech Alliance to Propel Innovation
The UK BioIndustry Association (BIA) is joining forces with the Japan Bioindustry…
From Genomics to Generative AI: Japan’s Bold Step in Personalized Medicine
The planet can no longer treat all people alike. Universal healthcare system…
Asahi Kasei expands Sonanos with next-gen excipients
Asahi Kasei, a leading healthcare materials provider, is growing its Sonanos™ excipient…
Alpha Fusion and Kobe Hospital launch At-211 Drug system
Alpha Fusion Inc. has announced a strategic collaboration with Kobe City Medical…
Celaid Therapeutics Raises ¥1.05B for Stem Cell Growth
Celaid Therapeutics Inc. announced that it successfully completed the first close of…
Panasonic Launches Facial Analysis Tool for Brain Health
Panasonic Holdings unveiled its "Estimated BHQ" system, a novel brain health measurement…
English